col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


227 Results       Page 1

 [1] 
Oxford University Press: The Journal of Infectious Diseases
  original article Date Title Authors   All Authors
1 [GO] 2022―May―17 Third-dose BNT162b2 vaccination elicits markedly high-level SARS-CoV-2-neutralizing antibodies in vaccinees who poorly responded to second dose in Japan Masayuki Amano, Kenji Maeda, Kiyoto Tsuchiya, Shinya Shimada, Hiroaki Mitsuya
2 [GO] 2022―May―16 Real World Evidence of the Neutralizing Monoclonal Antibody Sotrovimab for Preventing Hospitalization and Mortality in COVID-19 Outpatients Neil R. Aggarwal, Laurel E. Beaty, Tellen D. Bennett, Nichole E. Carlson, Christopher B. Davis, Bethany M. Kwan, et al. (+8)
3 [GO] 2022―May―13 Association of SARS-CoV-2 infection and related mortality with mental disorders: an epidemiological correlation in the Indian population Sunali Padhi, Nisha Nayak, Surjyapratap Sarangi, Suraj Kumar Nahak, Abhijit Pati, Bidyutprabha Pradhan, et al. (+2)
4 [GO] 2022―May―10 Virological and serological assessment of U.S. Army trainees isolated for COVID-19 Shilpa Hakre, Ines Elakhal Naouar, David B. King, Jennifer L. Burns, Kenya N. Jackson, Stephen W. Krauss, et al. (+22)
5 [GO] 2022―May―10 Older adults mount less durable humoral responses to two doses of COVID-19 mRNA vaccine, but strong initial responses to a third dose Francis Mwimanzi, Hope R. Lapointe, Peter K. Cheung, Yurou Sang, Fatima Yaseen, Gisele Umviligihozo, et al. (+24)
6 [GO] 2022―May―05 Waning immunity against respiratory syncytial virus during the COVID-19 pandemic Frederic Reicherz, Rui Yang Xu, Bahaa Abu-Raya, Abdelilah Majdoubi, Christina Michalski, Liam Golding, et al. (+9)
7 [GO] 2022―May―04 Antibody duration after infection from SARS-CoV-2 in the Texas Coronavirus Antibody Response Survey. Michael D. Swartz, Stacia M. DeSantis, Ashraf Yaseen, Frances A. Brito, Melissa A. Valerio-Shewmaker, Sarah E. Messiah, et al. (+17)
8 [GO] 2022―May―03 Low risk of SARS-CoV-2 transmission by fomites - a clinical observational study in highly infectious COVID-19 patients Toni Luise Meister, Marielen Dreismeier, Elena Vidal Blanco, Yannick Brüggemann, Natalie Heinen, Günter Kampf, et al. (+7)
9 [GO] 2022―May―03 Impact of COVID-19 Severity on Long-term Events in US Veterans using the Veterans Affairs Severity Index for COVID-19 (VASIC) Ashley Galloway, Yojin Park, Vidisha Tanukonda, Yuk-Lam Ho, Xuan-Mai T. Nguyen, Monika Maripuri, et al. (+15)
10 [GO] 2022―May―03 Cross-neutralizing activity against Omicron could be obtained in SARS-CoV-2 convalescent patients who received two doses of mRNA vaccination Yukiya Kurahashi, Koichi Furukawa, Silvia Sutandhio, Lidya Handayani Tjan, Sachiyo Iwata, Shigeru Sano, et al. (+10)
11 [GO] 2022―May―03 SARS-CoV-2 virus dynamics in recently infected people - data from a household transmission study Alexandra M. Mellis, Jennifer K. Meece, Natasha B. Halasa, James D. Chappell, Huong Q. McLean, Carlos G. Grijalva, et al. (+8)
12 [GO] 2022―Apr―25 Protection by vaccines and previous infection against the Omicron variant of SARS-CoV-2 Martin Šmíd, Luděk Berec, Lenka Přibylová, Ondřej Májek, Tomáš Pavlík, Jiří Jarkovský, et al. (+3)
13 [GO] 2022―Apr―21 Protection of Hamsters Challenged with SARS-CoV-2 Delta Variant after Two Doses of Adjuvanted SARS-CoV-2 Stabilized Prefusion Spike Protein (S-2P) and a Single Dose of Beta Variant S-2P Tsun-Yung Kuo, Chia En Lien, Yi-Jiun Lin, Meei-Yun Lin, Chung-Chin Wu, Wei-Hsuan Tang, et al. (+6)
14 [GO] 2022―Apr―15 SARS-CoV-2 anti-spike antibody levels following second dose of ChAdOx1 nCov-19 or BNT162b2 in residents of long-term care facilities in England (VIVALDI) Oliver Stirrup, Maria Krutikov, Gokhan Tut, Tom Palmer, David Bone, Rachel Bruton, et al. (+18)
15 [GO] 2022―Apr―15 Delta infection following vaccination elicits potent neutralizing immunity against the SARS-CoV-2 Omicron Ka-Li Zhu, Hui-Xia Gao, Lin Yao, Jun Rong, Li Yang, Zhi Zhang, et al. (+5)
16 [GO] 2022―Apr―14 Global Prevalence of Post COVID-19 Condition or Long COVID: A Meta-Analysis and Systematic Review Chen Chen, Spencer R. Haupert, Lauren Zimmermann, Xu Shi, Lars G. Fritsche, Bhramar Mukherjee
17 [GO] 2022―Apr―14 Impact of preexisting anti-Ad26 humoral immunity on immunogenicity of the Ad26.COV2.S COVID-19 vaccine Mathieu Le Gars, Jerald Sadoff, Frank Struyf, Dirk Heerwegh, Carla Truyers, Jenny Hendriks, et al. (+5)
18 [GO] 2022―Apr―06 mRNA Vaccine Effectiveness Against COVID-19 Hospitalization Among Solid Organ Transplant Recipients Jennie H Kwon, Mark W Tenforde, Manjusha Gaglani, H Keipp Talbot, Adit A Ginde, Tresa McNeal, et al. (+49)
19 [GO] 2022―Mar―28 The Concept of Classical Herd Immunity May Not Apply to COVID-19 David M Morens, Gregory K Folkers, Anthony S Fauci
20 [GO] 2022―Mar―16 Persistent Antibody Responses up to 18 Months after Mild SARS-CoV-2 Infection Pyoeng Gyun Choe, Jisu Hong, Jiyoung Park, Euijin Chang, Chang Kyung Kang, Nam Joong Kim, et al. (+3)
21 [GO] 2022―Mar―14 TNFRSF1B and TNF variants are associated with differences in soluble TNF receptors' levels in patients with severe COVID-19 Ingrid Fricke-Galindo, Ivette Buendía-Roldán, Andy Ruiz, Yadira Palacios, Gloria Pérez-Rubio, Rafael de Jesus Hernández-Zenteno, et al. (+15)
22 [GO] 2022―Mar―08 Corrigendum to: Longitudinal Analysis of Human Memory T-Cell Response According to the Severity of Illness up to 8 Months After Severe Acute Respiratory Syndrome Coronavirus 2 Infection Chang Kyung Kang, Minji Kim, Soojin Lee, Gwanghun Kim, Pyoeng Gyun Choe, Wan Beom Park, et al. (+8)
23 [GO] 2022―Mar―07 IgG response to SARS-CoV-2 and seasonal coronaviruses contributes to complement overactivation in severe COVID-19 patients Priscila M S Castanha, Dylan J Tuttle, Georgios D Kitsios, Jana L Jacobs, Ulisses Braga-Neto, Matthew Duespohl, et al. (+16)
24 [GO] 2022―Mar―02 Infants Younger Than 6 Months Infected With SARS-CoV-2 Show the Highest Respiratory Viral Loads Chi-Ching Kao, Yung-Po Liaw
25 [GO] 2022―Feb―28 SARS-CoV-2 nucleocapsid urine antigen in hospitalized patients with Covid-19 Nicolas Veyrenche, Amandine Pisoni, Ségolène Debiesse, Karine Bollore, Anne-Sophie Bedin, Alain Makinson, et al. (+6)
26 [GO] 2022―Feb―18 Longitudinal Systemic and Mucosal Immune Responses to SARS-CoV-2 Infection Peter F Wright, Alejandra C Prevost-Reilly, Harini Natarajan, Elizabeth B Brickley, Ruth I Connor, Wendy F Wieland-Alter, et al. (+4)
27 [GO] 2022―Feb―16 Hospitalization and Mortality Risk for COVID-19 Cases With SARS-CoV-2 AY.4.2 (VUI-21OCT-01) Compared to Non-AY.4.2 Delta Variant Sublineages Tommy Nyberg, Katie Harman, Asad Zaidi, Shaun R Seaman, Nick Andrews, Sophie G Nash, et al. (+11)
28 [GO] 2022―Feb―15 Characterization of the immune resistance of SARS-CoV-2 Mu variant and the robust immunity induced by Mu infection Keiya Uriu, Paúl Cárdenas, Erika Muñoz, Veronica Barragan, Yusuke Kosugi, Kotaro Shirakawa, et al. (+2)
29 [GO] 2022―Feb―14 Duration of humoral immunity and cross-neutralizing activity against the Alpha, Beta, and Delta variants after wild-type SARS-CoV-2 infection: A prospective cohort study Ji Yun Noh, Jeong-Sun Yang, Soon Young Hwang, Hakjun Hyun, Hye Seong, Jin Gu Yoon, et al. (+7)
30 [GO] 2022―Feb―14 Morbidity of Respiratory Syncytial Virus-infections (RSV): RSV compared with SARS-CoV-2 infections in children aged 0 - 4 years in Cologne, Germany Meike Meyer, Esra Ruebsteck, Frank Eifinger, Florian Klein, André Oberthuer, Silke Van-Koningsbruggen-Rietschel, et al. (+2)
31 [GO] 2022―Feb―09 Detection and kinetics of subgenomic SARS-CoV-2 RNA viral load in longitudinal diagnostic RNA positive samples Meagan E Deming, Tracy Q Dong, Vaidehi Agrawal, Margaret G Mills, Meei-Li W Huang, Alexander L Greninger, et al. (+16)
32 [GO] 2022―Feb―07 Distinct Homologous and Variant-Specific Memory B-Cell and Antibody Response Over Time after SARS-CoV-2 mRNA Vaccination Iana H Haralambieva, Jonathon M Monroe, Inna G Ovsyannikova, Diane E Grill, Gregory A Poland, Richard B Kennedy
33 [GO] 2022―Jan―25 Comparative single-dose mRNA and ChAdOx1 vaccine effectiveness against SARS-CoV-2, including variants of concern: test-negative design, British Columbia, Canada Danuta M Skowronski, Solmaz Setayeshgar, Macy Zou, Natalie Prystajecky, John R Tyson, Hind Sbihi, et al. (+12)
34 [GO] 2022―Jan―25 Phylogenomics of SARS-CoV-2 in Emergency Shelters for People Experiencing Homelessness Amanda M Casto, Julia H Rogers, Amy C Link, Michael Boeckh, Michael L Jackson, Timothy M Uyeki, et al. (+3)
35 [GO] 2022―Jan―24 SARS-CoV-2 DNA Vaccine INO-4800 Induces Durable Immune Responses Capable of Being Boosted in a Phase 1 Open-Label Trial Kimberly A Kraynyak, Elliott Blackwood, Joseph Agnes, Pablo Tebas, Mary Giffear, Dinah Amante, et al. (+30)
36 [GO] 2022―Jan―12 SARS-CoV-2 Effects at the Maternal-Fetal Interface Roberta L DeBiasi
37 [GO] 2022―Jan―12 Understanding the potential drivers for respiratory syncytial virus rebound during the COVID-19 pandemic You Li, Xin Wang, Bingbing Cong, Shuyu Deng, Daniel R Feikin, Harish Nair
38 [GO] 2022―Jan―11 Intrauterine fetal demise in the third trimester of pregnancy associated with mild infection with the SARS-CoV-2 Delta variant without protection from vaccination Minhui Guan, Eric Johannesen, Cynthia Y Tang, Albert L Hsu, Courtney L Barnes, Megan Burnam, et al. (+2)
39 [GO] 2022―Jan―11 SARS-CoV-2 placentitis associated with B.1.617.2 (Delta) variant and fetal distress or demise Lydia L Shook, Sara Brigida, James Regan, James P Flynn, Abbas Mohammadi, Behzad Etemad, et al. (+5)
40 [GO] 2022―Jan―04 Effect of influenza vaccination on risk of COVID-19 - A prospective cohort study of 46,000 health care workers Jonas Henrik Kristensen, Rasmus Bo Hasselbalch, Mia Pries-Heje, Pernille Brok Nielsen, Andreas Dehlbæk Knudsen, Kamille Fogh, et al. (+23)
41 [GO] 2022―Jan―03 Lung function decline in relation to COVID-19 in the general population: a matched cohort study with pre-pandemic assessment of lung function Katrine K Iversen, Shoaib Afzal, Magnus G Ahlström, Børge G Nordestgaard, Uffe V Schneider, Lene Nielsen, et al. (+3)
42 [GO] 2022―Jan―02 Serum levels of pro-inflammatory lipid mediators and specialised pro-resolving molecules are increased in SARS-CoV-2 patients and correlate with markers of the adaptive immune response James Turnbull, Rakesh Jha, Catherine A Ortori, Eleanor Lunt, Patrick J Tighe, William L Irving, et al. (+6)
43 [GO] 2022―Jan―01 SARS-CoV-2 variant exposures elicit antibody responses with differential cross-neutralization of established and emerging strains including Delta and Omicron Matthew T Laurie, Jamin Liu, Sara Sunshine, James Peng, Douglas Black, Anthea M Mitchell, et al. (+11)
44 [GO] 2021―Dec―27 Immunogenicity and Safety of a Three-Dose Regimen of a SARS-CoV-2 Inactivated Vaccine in Adults: A Randomized, Double-blind, Placebo-controlled Phase 2 Trial Jiankai Liu, Baoying Huang, Guifan Li, Xianyun Chang, Yafei Liu, Kai Chu, et al. (+9)
45 [GO] 2021―Dec―22 Morbidity and Mortality Among Adults Experiencing Homelessness Hospitalized With COVID-19 Chang Yun Hsin, Kao Chi Ching, Fang Jia Jun, Yung-Heng Lee, James Cheng-Chung Wei
46 [GO] 2021―Dec―22 Year-long COVID-19 infection reveals within-host evolution of SARS-CoV-2 in a patient with B cell depletion Veronique Nussenblatt, Allison E Roder, Sanchita Das, Emmie de Wit, Jung-Ho Youn, Stephanie Banakis, et al. (+9)
47 [GO] 2021―Dec―20 Consulting the Oracle of Chronic SARS-CoV-2 Infection Jacob E Lemieux, Jeremy Luban
48 [GO] 2021―Dec―14 Impact of Covid-19 on Tuberculosis Prevention and Treatment in Canada: a multicentre analysis of 10,833 patients Coralie Geric, Mariane Saroufim, David Landsman, Jonathan Richard, Andrea Benedetti, Jane Batt, et al. (+2)
49 [GO] 2021―Dec―13 High SARS-CoV-2 viral load and low CCL5 expression levels in the upper respiratory tract are associated with COVID-19 severity Felipe Pérez-García, María Martin-Vicente, Rosa Lía Rojas-García, Lucia Castilla-García, María José Muñoz-Gomez, Irene Hervás Fernández, et al. (+6)
50 [GO] 2021―Dec―09 Sequential delivery of LAIV and SARS-CoV-2 in the ferret model can reduce SARS-CoV-2 shedding and does not result in enhanced lung pathology Kathryn A Ryan, Katarzyna E Schewe, Jonathan Crowe, Susan A Fotheringham, Yper Hall, Richard Humphreys, et al. (+8)
51 [GO] 2021―Dec―08 Comparative immunogenicity and effectiveness of mRNA-1273, BNT162b2 and Ad26.COV2.S COVID-19 vaccines Vivek Naranbhai, Wilfredo F Garcia-Beltran, Christina C Chang, Cristhian Berrios Mairena, Julia C Thierauf, Grace Kirkpatrick, et al. (+19)
52 [GO] 2021―Dec―07 Reduced magnitude and durability of humoral immune responses to COVID-19 mRNA vaccines among older adults Mark A Brockman, Francis Mwimanzi, Hope R Lapointe, Yurou Sang, Olga Agafitei, Peter Cheung, et al. (+20)
53 [GO] 2021―Dec―01 Maternal-fetal immunologic response to SARS-CoV-2 infection in a symptomatic vulnerable population: A prospective cohort Ramon Larcade, Lise DeShea, Gillian A Lang, Mauricio T Caballero, Adrian Ferretti, William H Beasley, et al. (+6)
54 [GO] 2021―Nov―29 Gene Expression Risk Scores for COVID-19 Illness Severity Derick R Peterson, Andrea M Baran, Soumyaroop Bhattacharya, Angela R Branche, Daniel P Croft, Anthony M Corbett, et al. (+3)
55 [GO] 2021―Nov―16 COVID-19 Vaccination Rates in a Global HIV Cohort Evelynne S Fulda, Kathleen V Fitch, Edgar T Overton, Markella V Zanni, Judith A Aberg, Judith S Currier, et al. (+8)
56 [GO] 2021―Nov―15 COVID-19 mRNA Vaccine Immunogenicity in Immunosuppressed Individuals Ai-Ris Y Collier, Jingyou Yu, Katherine Mcmahan, Jinyan Liu, Caroline Atyeo, Jessica L Ansel, et al. (+15)
57 [GO] 2021―Nov―10 Corrigendum to: Lesbian, Gay, Bisexual, Transgender, and Queer (LGBTQ+) Communities and the Coronavirus Disease 2019 Pandemic: A Call to Break the Cycle of Structural Barriers Raul Macias Gil, Tracey L Freeman, Trini Mathew, Ravina Kullar, Thomas Fekete, Anais Ovalle, et al. (+5)
58 [GO] 2021―Nov―06 Effects of SARS-CoV-2 strain variation on virus neutralisation titres: therapeutic use of convalescent plasma Dung Nguyen, Julie Xiao, Peter Simmonds, Abigail Lamikanra, Valerie Odon, Jeremy Ratcliff, et al. (+3)
59 [GO] 2021―Nov―05 SARS-CoV-2 monoclonal antibody combination therapy in patients with COVID-19 and primary antibody deficiency Federica Pulvirenti, Cinzia Milito, Francesco Cinetto, Ane Fernandez Salinas, Sara Terreri, Eva Piano Mortari, et al. (+8)
60 [GO] 2021―Oct―28 Longitudinal immune profiling of a SARS-CoV-2 reinfection in a solid organ transplant recipient Jonathan Klein, Anderson F Brito, Paul Trubin, Peiwen Lu, Patrick Wong, Tara Alpert, et al. (+25)
61 [GO] 2021―Oct―20 Durability of SARS-CoV-2-specific T cell responses at 12-months post-infection Zhongyan Lu, Eric D Laing, Jarina Pena DaMata, Katherine Pohida, Marana S Tso, Emily C Samuels, et al. (+25)
62 [GO] 2021―Oct―12 Frequent Sars-Cov-2 Antigen Testing In A Disease-Free Population C S Lau, T C Aw
63 [GO] 2021―Oct―11 Angiotensin-converting enzyme 2 (ACE-2) genetic variants are associated with coronavirus disease 19 Abhijit Pati, Sunali Padhi, Tapan Kumar Singh Nayak, Aditya K Panda
64 [GO] 2021―Oct―04 Risk factors for COVID-19 deaths among elderly nursing home Medicare beneficiaries in the pre-vaccine period Yun Lu, Yixin Jiao, David J Graham, Yue Wu, Jing Wang, Mikhail Menis, et al. (+5)
65 [GO] 2021―Sep―20 Quantifying the impact of COVID-19 non-pharmaceutical interventions on influenza transmission in the United States Yuchen Qi, Jeffrey Shaman, Sen Pei
66 [GO] 2021―Sep―20 The impact of real-time whole genome sequencing in controlling healthcare-associated SARS-CoV-2 outbreaks Rodric V Francis, Harriet Billam, Mitch Clarke, Carl Yates, Theocharis Tsoleridis, Louise Berry, et al. (+7)
67 [GO] 2021―Sep―17 Plasma from post-COVID-19 and COVID-19-Vaccinated Donors Results in Highly Potent SARS-CoV-2 Neutralization by Intravenous Immunoglobulins Michael Karbiener, Maria R Farcet, Julia Schwaiger, Nicholas Powers, James Lenart, Joseph M Stewart, et al. (+2)
68 [GO] 2021―Sep―11 The impact of co-circulating pathogens on SARS-CoV-2/COVID-19 Surveillance How concurrent epidemics may introduce bias and decrease the observed SARS-CoV-2 percent positivity Aleksandra Kovacevic, Rosalind M Eggo, Marc Baguelin, Matthieu Domenech de Cellès, Lulla Opatowski
69 [GO] 2021―Sep―10 Dynamics of the cellular and humoral immune response after BNT162b2 mRNA Covid-19 vaccination in Covid-19 naive nursing home residents Jens T Van Praet, Stefaan Vandecasteele, Anneleen De Roo, Matthijs Vynck, An S De Vriese, Marijke Reynders
70 [GO] 2021―Sep―08 mRNA Vaccine Effectiveness against COVID-19 among Symptomatic Outpatients Aged ≥16 Years in the United States, February - May 2021 Sara S Kim, Jessie R Chung, Edward A Belongia, Huong Q McLean, Jennifer P King, Mary Patricia Nowalk, et al. (+16)
71 [GO] 2021―Sep―08 Baseline SARS-CoV-2 Viral Load is Associated With COVID-19 Disease Severity and Clinical Outcomes: Post-Hoc Analyses of a Phase 2/3 Trial Anita Boyapati, Matthew F Wipperman, Peter J Ehmann, Sara Hamon, David J Lederer, Alpana Waldron, et al. (+7)
72 [GO] 2021―Sep―07 Characteristics of Persons with Secondary Detection of SARS-CoV-2 ≥90 days After First Detection - New Mexico, 2020 Joseph T Hicks, Smita Das, Almea Matanock, Anastacia Griego-Fisher, Daniel Sosin
73 [GO] 2021―Sep―04 Persistence of the immune responses and cross-neutralizing activity with Variants of Concern following two doses of adjuvanted SCB-2019 COVID-19 vaccine Peter C Richmond, Lara Hatchuel, Filippo Pacciarini, Branda Hu, Igor Smolenov, Ping Li, et al. (+4)
74 [GO] 2021―Aug―24 Potential effect of previous HCoV-NL63 infection on the rate of infection and the clinical course of COVID-19 M Hukić, H Avdihodžić, E Veledar, E Korkut
75 [GO] 2021―Aug―24 Critically ill COVID-19 patients exhibit hyperactive cytokine responses associated with effector exhausted senescent T cells in acute infection Angélica Arcanjo, Kamila Guimarães Pinto, Jorgete Logullo, Paulo Emílio Corrêa Leite, Camilla Cristie Barreto Menezes, Leonardo Freire-de-Lima, et al. (+13)
76 [GO] 2021―Aug―24 SARS-CoV-2 infectivity correlates with high viral loads and detection of viral antigen and is terminated by seroconversion Felix Buder, Markus Bauswein, Clara L Magnus, Franz A�rt, Henriette Lang, Christof Kundel, et al. (+15)
77 [GO] 2021―Aug―21 Joint Estimation Of Generation Time And Incubation Period For Coronavirus Disease (Covid-19) Yiu Chung Lau, Tim K Tsang, Lee Kennedy-Shaffer, Rebecca Kahn, Eric H Y Lau, Dongxuan Chen, et al. (+4)
78 [GO] 2021―Aug―18 Seasonal coronavirus pneumonia after SARS-Cov-2 infection and vaccine: new frenemies? Rosa de Miguel Buckley, Marta Díaz-Menéndez, Julio García-Rodríguez, José Ramón Arribas
79 [GO] 2021―Aug―18 SARS-CoV-2 variant Delta infects all 6 siblings but spares Comirnaty (BNT162b2, BioNTech/Pfizer)-vaccinated parents Nadia Nathan, Blandine Prevost, Sidonie Lambert, Aurélie Schnuriger, Harriet Corvol
80 [GO] 2021―Aug―17 Interpreting prevention of COVID-19 and vaccines Chi Ya Yang, Yi Yang Lee, James Cheng-Chung Wei
81 [GO] 2021―Aug―12 Determinants and dynamics of SARS-CoV-2 infection in a diverse population: 6-month evaluation of a prospective cohort study Daniel B Horton, Emily S Barrett, Jason Roy, Maria Laura Gennaro, Tracy Andrews, Patricia Greenberg, et al. (+20)
82 [GO] 2021―Aug―11 SARS-CoV-2 Specific Monoclonal Antibody for the Treatment of Mild-to-Moderate COVID-19 in Cancer Patients: A Single-center Experience Alfredo G Puing, Stephanie Ho, Paul Frankel, Bernard Tegtmeier, Abigail Martin, Justine Ross, et al. (+6)
83 [GO] 2021―Aug―09 Distinct mitochondria-mediated T cells apoptosis responses in children and adults with COVID-19 Yang Yang, Kuang Liangjian, Linhai Li, Wu Yongjian, Bei Zhong, Xi Huang
84 [GO] 2021―Jul―30 Editorial: COVID-19 severity in obese patients may be linked to viral load and immune response Alexander M Lewis, Xinya Zhang, Jonathan R  Brestoff
85 [GO] 2021―Jul―30 Clinical, immunological and virological SARS-CoV-2 phenotypes in obese and non-obese military health system beneficiaries Nusrat J Epsi, Stephanie A Richard, Eric D Laing, Anthony C Fries, Eugene Millar, Mark P Simons, et al. (+17)
86 [GO] 2021―Jul―29 SARS-CoV-2 normalized viral loads and subgenomic RNA detection as tools for improving clinical decision-making and work reincorporation Marta Santos Bravo, David Nicolás, Carla Berengua, Mariana Fernandez, Juan Carlos Hurtado, Marta Tortajada, et al. (+5)
87 [GO] 2021―Jul―28 The LGBTQ+ communities and the COVID-19 pandemic: a call to break the cycle of structural barriers Raul Macias Gil, Tracey Freeman, Trini Mathew, Ravina Kullar, Anais Ovalle, Don Nguyen, et al. (+4)
88 [GO] 2021―Jul―22 Higher viral load drives infrequent SARS-CoV-2 transmission between asymptomatic residence hall roommates Kristen K Bjorkman, Tassa K Saldi, Erika Lasda, Leisha Conners Bauer, Jennifer Kovarik, Patrick K Gonzales, et al. (+10)
89 [GO] 2021―Jul―21 Inter-subject variation in ACE2 protein expression in human airway epithelia and its relationship to SARS-CoV-2 infection Kun Li, Christine Wohlford-Lenane, Jennifer A Bartlett, Paul B McCray
90 [GO] 2021―Jul―19 Kinetics of the SARS-CoV-2 antibody response and serological estimation of time since infection Stéphane Pelleau, Tom Woudenberg, Jason Rosado, Françoise Donnadieu, Laura Garcia, Thomas Obadia, et al. (+37)
91 [GO] 2021―Jul―17 Real-World Clinical Outcomes of Bamlanivimab and Casirivimab-Imdevimab among High-Risk Patients with Mild to Moderate Coronavirus Disease 2019 Ravindra Ganesh, Lindsey M Philpot, Dennis M Bierle, Ryan J Anderson, Lori L Arndt, Richard F Arndt, et al. (+13)
92 [GO] 2021―Jul―16 Not All Monoclonal Antibodies for COVID-19 Are Created Equal Valentina Stosor, Michael P Angarone
93 [GO] 2021―Jul―13 SARS-CoV-2 B.1.617 mutations L452 and E484Q are not synergistic for antibody evasion Isabella Ferreira, Steven Kemp, Rawlings Datir, Akatsuki Saito, Bo Meng, Partha Rakshit, et al. (+11)
94 [GO] 2021―Jul―12 Corrigendum to: SARS-CoV-2 Serologic Assays in Control and Unknown Populations Demonstrate the Necessity of Virus Neutralization Testing Jennifer A Rathe, Emily A Hemann, Julie Eggenberger, Zhaoqi Li, Megan L Knoll, Caleb Stokes, et al. (+5)
95 [GO] 2021―Jul―12 Cross-sectional assessment of SARS-CoV-2 viral load by symptom status in Massachusetts congregate living facilities Niall J Lennon, Roby P Bhattacharyya, Michael J Mina, Heidi L Rehm, Deborah T Hung, Sandra Smole, et al. (+3)
96 [GO] 2021―Jul―08 Molnupiravir inhibits the replication of the emerging SARS-CoV-2 variants of concern (VoCs) in a hamster infection model Rana Abdelnabi, Caroline S Foo, Steven De Jonghe, Piet Maes, Birgit Weynand, Johan Neyts
97 [GO] 2021―Jul―02 Epidemiologic, immunologic, and virus characteristics in patients with paired SARS-CoV-2 serology and reverse transcription polymerase chain reaction testing Talya Shragai, Sarah E Smith-Jeffcoat, Mitsuki Koh, Marcos C Schechter, Paulina A Rebolledo, Vyjayanti Kasinathan, et al. (+19)
98 [GO] 2021―Jul―02 Limited neutralization of authentic SARS-CoV-2 variants carrying E484K in vitro Marek Widera, Alexander Wilhelm, Sebastian Hoehl, Christiane Pallas, Niko Kohmer, Timo Wolf, et al. (+7)
99 [GO] 2021―Jun―30 Longitudinal Serological Analysis following National Seroprevalence Study to Investigate COVID-19 Infection in People Living in Ireland Andrew Beverland, Mary Keogan, Jeff Connell, Cillian De Gascun, Derval Igoe
100 [GO] 2021―Jun―29 Comment on: Cell adhesion molecules and vascular endothelial growth factor at the systemic and alveolar level in COVID-19 ARDS Ming Tong, Qing Zheng, Fang Chen, Yimin Zhu
101 [GO] 2021―Jun―29 Cell adhesion molecules and vascular endothelial growth factor at the systemic and alveolar level in COVID-19 ARDS Markus K Kristensen, Ronni R Plovsing, Ronan M G Berg, Rikke Krogh Madsen, Andreas Ronit
102 [GO] 2021―Jun―24 Persistence of Neutralizing Antibody Response up to One Year after Asymptomatic or Symptomatic SARS-CoV-2 infection Pyoeng Gyun Choe, Chang Kyung Kang, Kye-Hyung Kim, Jongyoun Yi, Eu Suk Kim, San Won Park, et al. (+3)
103 [GO] 2021―Jun―22 Detection of serum cross-reactive antibodies and memory response to SARS-CoV-2 in pre-pandemic and post-COVID-19 convalescent samples Khalid Sharwani, Ravi Sharma, Madhan Krishnan, Terry Jones, Martin Mayora-Neto, Diego Cantoni, et al. (+7)
104 [GO] 2021―Jun―21 Accelerating the evolution of SARS-CoV-2 - a risk of combining dexamethasone and tocilizumab for severe COVID-19 David Koeckerling, Joseph Barker
105 [GO] 2021―Jun―19 Early Convalescent Plasma Therapy and Mortality among US Veterans Hospitalized with Non-Severe COVID-19: An Observational Analysis Emulating a Target Trial Kelly Cho, Sarah C Keithly, Katherine E Kurgansky, Arin L Madenci, Hanna Gerlovin, Helen M Wellman, et al. (+18)
106 [GO] 2021―Jun―16 Large-scale identification of T cell epitopes derived from SARS-CoV-2 for the development of peptide vaccines against COVID-19 Yipeng Ma, Fenglan Liu, Tong Lin, Lei Chen, Aixin Jiang, Geng Tian, et al. (+2)
107 [GO] 2021―Jun―15 Epidemiology of reported HIV and other sexually transmitted infections during the COVID-19 pandemic, New York City Sarah L Braunstein, Jennifer Sanderson Slutsker, Rachael Lazar, Dipal Shah, Robin R Hennessy, Shirley Chen, et al. (+3)
108 [GO] 2021―Jun―09 COVID-19 mRNA vaccination generates greater IgG levels in women compared to men Alexis R Demonbreun, Amelia Sancilio, Matt E Velez, Daniel T Ryan, Lorenzo Pesce, Rana Saber, et al. (+7)
109 [GO] 2021―Jun―07 Proper assignation of reactivation in a COVID-19 recurrence initially interpreted as a reinfection Laura Pérez Lago, Helena Martínez Lozano, Jose Antonio Pajares Díaz, Arantxa Díaz Gómez, Marina Machado, Pedro J Sola-Campoy, et al. (+11)
110 [GO] 2021―Jun―04 Marked increase in avidity of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) antibodies 7-8 months after infection is not diminished in old age Daniel Pichler, Matthias Baumgartner, Janine Kimpel, Annika Rössler, Lydia Riepler, Katie Bates, et al. (+4)
111 [GO] 2021―Jun―04 Naturally acquired SARS-CoV-2 immunity persists for up to 11 months following infection Valeria De Giorgi, Kamille A West, Amanda N Henning, Leonard N Chen, Michael R Holbrook, Robin Gross, et al. (+7)
112 [GO] 2021―Jun―04 A multiregional evaluation of Ct values in SARS-CoV-2 VOC-20DEC-01 variant K J Hill, R Dewar, K Templeton
113 [GO] 2021―Jun―03 Accounting for imported cases in estimating the time-varying reproductive number of COVID-19 in Hong Kong Tim K Tsang, Peng Wu, Eric H Y Lau, Benjamin J Cowling
114 [GO] 2021―Jun―03 Clarification regarding Outdoor Transmission of SARS-CoV-2 and Other Respiratory Viruses, a Systematic Review Nooshin Razani, Mohsen Malekinejad, George W Rutherford
115 [GO] 2021―Jun―03 Prevalence of SARS-CoV-2 antibodies in New York City adults, June-October, 2020: a population-based survey Jannae C Parrott, Ariana N Maleki, Valerie E Vassor, Sukhminder Osahan, Yusyin Hsin, Michael Sanderson, et al. (+9)
116 [GO] 2021―May―31 Corrigendum to: Suboptimal Biological Sampling as a Probable Cause of False-Negative COVID-19 Diagnostic Test Results Natalie N Kinloch, Gordon Ritchie, Chanson J Brumme, Winnie Dong, Weiyan Dong, Tanya Lawson, et al. (+8)
117 [GO] 2021―May―25 SARS-CoV-2 neutralizing human antibodies protect against lower respiratory tract disease in a hamster model Bart L Haagmans, Danny Noack, Nisreen M A Okba, Wentao Li, Chunyan Wang, Theo Bestebroer, et al. (+16)
118 [GO] 2021―May―06 Prolonged COVID-19 Disease in a Patient with Rheumatoid Arthritis on Rituximab Therapy Rachel Aviv, Andrew Weber, Tarif Anzum, Matthew Federbush, Diane Horowitz, Effie Singas
119 [GO] 2021―May―05 β-D-N 4-hydroxycytidine (NHC) Inhibits SARS-CoV-2 Through Lethal Mutagenesis But Is Also Mutagenic To Mammalian Cells Shuntai Zhou, Collin S Hill, Sanjay Sarkar, Longping V Tse, Blaide M D Woodburn, Raymond F Schinazi, et al. (+4)
120 [GO] 2021―Apr―23 Activating Killer-cell Immunoglobulin-like Receptors are associated with the severity of COVID-19 Enrique Bernal, Lourdes Gimeno, María J Alcaraz, Ahmed A Q귮r, Marta Moreno, María V Martínez-Sánchez, et al. (+13)
121 [GO] 2021―Apr―20 Corrigendum to: Human Challenge Studies Are Unlikely to Accelerate Coronavirus Vaccine Licensure due to Ethical and Practical Issues Stanley M Spinola, Gregory D Zimet, Mary A Ott, Barry P Katz
122 [GO] 2021―Apr―06 A Silver Lining? Fewer non-SARS-CoV-2 Respiratory Viruses during the COVID-19 Pandemic Zachary M Most, Michael Holcomb, Andrew R Jamieson, Trish M Perl
123 [GO] 2021―Mar―23 Navigating the uncertainties of COVID-19 associated aspergillosis (CAPA): A comparison with influenza associated aspergillosis (IAPA) Frederic Lamoth, Russell E Lewis, Thomas J Walsh, Dimitrios P Kontoyiannis
124 [GO] 2021―Mar―20 Longitudinal Analysis of Human Memory T-Cell Response according to the Severity of Illness up to 8 Months after SARS-CoV-2 Infection Chang Kyung Kang, Minji Kim, Soojin Lee, Gwanghun Kim, Pyoeng Gyun Choe, Wan Beom Park, et al. (+8)
125 [GO] 2021―Mar―19 Anti-SARS-CoV2 antibody responses in serum and cerebrospinal fluid of COVID-19 patients with neurological symptoms Janet L Cunningham, Johan Virhammar, Bengt Rönnberg, Xaquin Castro Dopico, Linda Kolstad, Bo Albinsson, et al. (+9)
126 [GO] 2021―Mar―15 Rapidly Increasing SARS-CoV-2 Neutralization by Intravenous Immunoglobulins Produced from Plasma Collected During the 2020 Pandemic Maria R Farcet, Michael Karbiener, Julia Schwaiger, Reinhard Ilk, Thomas R Kreil
127 [GO] 2021―Mar―13 Role of asymptomatic children in community SARS-CoV-2 transmission Liangjian Lu, Chee Teck Koh, Yi Herng Lim, Andrew Sng, Kok Siong Poon, Shaun S Y Tan, et al. (+5)
128 [GO] 2021―Mar―11 Comment on: Nature and Dimensions of the Systemic Hyper-Inflammation and its Attenuation by Convalescent Plasma in Severe COVID-19 Yeny Acosta-Ampudia, Manuel Rojas, Diana M Monsalve, Yhojan Rodríguez, Carolina Ramírez-Santana, Juan-Manuel Anaya
129 [GO] 2021―Mar―11 Complement Induced Endotheliopathy Associated Vascular Microthrombosis in Coronavirus 2019 Disease H Bradford Hawley, Jae C Chang
130 [GO] 2021―Mar―09 The Association of COVID-19 Risk Perception, County Death Rates, and Voluntary Health Behaviors among U.S. Adult Population Jad A Elharake, Mehr Shafiq, SarahAnn M McFadden, Amyn A Malik, Saad B Omer
131 [GO] 2021―Feb―18 Susceptibility and Attenuated Transmissibility of SARS-CoV-2 in Domestic Cats Linlin Bao, Zhiqi Song, Jing Xue, Hong Gao, Jiangning Liu, Jie Wang, et al. (+21)
132 [GO] 2021―Feb―16 The Cat’s in the Bag: Despite limited cat-to-cat SARS-CoV-2 transmission, One Health surveillance efforts are needed Meghan F Davis, Gabriel K Innes
133 [GO] 2021―Feb―12 Viral load of SARS-CoV-2 in adults during the first and second wave of COVID-19 pandemic in Houston, TX: the potential of the super-spreader Vasanthi Avadhanula, Erin G Nicholson, Laura Ferlic-Stark, Felipe-Andres Piedra, Brittani N Blunck, Sonia Fragoso, et al. (+9)
134 [GO] 2021―Feb―12 A Phase II Safety and Efficacy Study on Prognosis of Moderate Pneumonia in COVID-19 patients with Regular Intravenous Immunoglobulin Therapy Raman R S, Vijaykumar Bhagwan Barge, Anil Kumar Darivenula, Himanshu Dandu, Rakesh R Kartha, Varun Bafna, et al. (+2)
135 [GO] 2021―Feb―11 High amounts of SARS-CoV-2 precede sickness among asymptomatic healthcare workers Joakim Dillner, K Miriam Elfström, Jonas Blomqvist, Lars Engstrand, Mathias Uhlén, Carina Eklund, et al. (+21)
136 [GO] 2021―Feb―03 UVB radiation alone may not explain sunlight inactivation of SARS-CoV-2 Paolo Luzzatto-Fegiz, Fernando Temprano-Coleto, François J Pea�rf, Julien R Landel, Yangying Zhu, Julie A McMurry
137 [GO] 2021―Jan―27 Human Monoclonal Antibody Cocktail for the Treatment or Prophylaxis of Middle Eastern Respiratory Syndrome Coronavirus (MERS-CoV) Sumathi Sivapalasingam, George A Saviolakis, Kirsten Kulcsar, Aya Nakamura, Thomas Conrad, Mohamed Hassanein, et al. (+12)
138 [GO] 2021―Jan―25 Role of cell adhesion molecules for disease development of patients with and without COVID-19 in the emergency department Wolfgang Bauer, Jannis Ulke, Noa Galtung, Leonore Claudia Strasser-Marsik, Nick Neuwinger, Rudolf Tauber, et al. (+2)
139 [GO] 2021―Jan―23 Monocytes and macrophages, targets of SARS-CoV-2: the clue for Covid-19 immunoparalysis Asma Boumaza, Laetitia Gay, Soraya Mezouar, Eloïne Bestion, Aïssatou Bailo Diallo, Moise Michel, et al. (+7)
140 [GO] 2021―Jan―19 Immune profiling reveals early disease trajectories associated with COVID-19 mortality: a sub-study from the ACTT-1 trial Joshua M Thiede, Abigail R Gress, Samuel D Libby, Christine E Ronayne, William E Matchett, Brooke Noren, et al. (+5)
141 [GO] 2021―Jan―02 Tropism of SARS-CoV-2, SARS-CoV and influenza virus in canine tissue explants Christine H T Bui, H W Yeung, John C W Ho, Connie Y H Leung, Kenrie P Y Hui, Ranawaka A P M Perera, et al. (+5)
142 [GO] 2020―Dec―23 SARS-CoV-2 Serologic Assays in Control and Unknown Populations Demonstrate the Necessity of Virus Neutralization Testing Jennifer A Rathe, Emily A Hemann, Julie Eggenberger, Zhaoqi Li, Megan L Knoll, Caleb Stokes, et al. (+5)
143 [GO] 2020―Dec―21 Fostamatinib Inhibits Neutrophils Extracellular Traps Induced by COVID-19 Patient Plasma: A Potential Therapeutic Jeffrey R Strich, Marcos J Ramos-Benitez, Davide Randazzo, Sydney R Stein, Ashley Babyak, Richard T Davey, et al. (+3)
144 [GO] 2020―Dec―14 Natural history of COVID-19: Risk factors for hospitalizations and deaths among >26 million U.S. Medicare beneficiaries Hector S Izurieta, David J Graham, Yixin Jiao, Mao Hu, Yun Lu, Yue Wu, et al. (+6)
145 [GO] 2020―Dec―03 Neutrophil more than platelet activation associates with thrombotic complications in COVID-19 patients E Petito, E Falcinelli, U Paliani, E Cesari, G Vaudo, M Sebastiano, et al. (+10)
146 [GO] 2020―Dec―02 SARS-CoV-2-induced immune activation and death of monocyte-derived human macrophages and dendritic cells Jian Zheng, Yuhang Wang, Kun Li, David K Meyerholz, Chantal Allamargot, Stanley Perlman
147 [GO] 2020―Nov―27 Outdoor Transmission of SARS-CoV-2 and Other Respiratory Viruses, a Systematic Review Tommaso Celeste Bulfone, Mohsen Malekinejad, George W Rutherford, Nooshin Razani
148 [GO] 2020―Nov―17 Monocyte CD169 expression as a biomarker in the early diagnosis of COVID-19 Anne-Sophie Bedin, Alain Makinson, Marie-Christine Picot, Frank Mennechet, Fabrice Malergue, Amandine Pisoni, et al. (+14)
149 [GO] 2020―Nov―12 Corrigendum to: Epidemiology of Severe Acute Respiratory Syndrome Coronavirus 2 Emergence Amidst Community-Acquired Respiratory Viruses Karoline Leuzinger, Tim Roloff, Rainer Gosert, Kirstin Sogaard, Klaudia Naegele, Katharina Rentsch, et al. (+12)
150 [GO] 2020―Nov―11 Long-term survival of SARS-CoV-2 on salmon as a source for international transmission Manman Dai, Huanan Li, Nan Yan, Jinyu Huang, Li Zhao, Siqi Xu, et al. (+4)
151 [GO] 2020―Nov―09 Corrigendum to: Clinical and Epidemiological Features of 46 Children <1 Year Old With Coronavirus Disease 2019 in Wuhan, China: A Descriptive Study Xinghua Liu, Jianqiao Tang, Rong Xie, Wei Li, Jianying Chen, Yan Guo, et al. (+8)
152 [GO] 2020―Nov―05 Possible auto-antigens that may explain the post-infection autoimmune manifestations in COVID-19 patients displaying neurological conditions Mugdha Mohkhedkar, Siva Sai Krishna Venigalla, Vani Janakiraman
153 [GO] 2020―Oct―28 On the effect of age on the transmission of SARS-CoV-2 in households, schools and the community E Goldstein, M Lipsitch, M Cevik
154 [GO] 2020―Oct―14 Independent side-by-side validation and comparison of four serological platforms for SARS-CoV-2 antibody testing Bernd Jahrsdörfer, Joris Kroschel, Carolin Ludwig, Victor Max Corman, Tatjana Schwarz, Sixten Körper, et al. (+8)
155 [GO] 2020―Oct―06 Rapid, sensitive and specific SARS coronavirus-2 detection: a multi-center comparison between standard qRT-PCR and CRISPR based DETECTR Eelke Brandsma, Han J M P Verhagen, Thijs J W van de Laar, Eric C J Claas, Marion Cornelissen, Emile van den Akker
156 [GO] 2020―Oct―06 Low incidence of reinfection with endemic coronaviruses diagnosed by RT-PCR Johan Ringlander, Staffan Nilsson, Johan Westin, Magnus Lindh, Anna Martner, Kristoffer Hellstrand
157 [GO] 2020―Oct―03 Upper respiratory tract levels of SARS-CoV-2 RNA and duration of viral RNA shedding do not differ between patients with mild and severe/critical COVID-19 Aylin Yilmaz, Emelie Marklund, Maria Andersson, Staffan Nilsson, Lars-Magnus Andersson, Magnus Lindh, Magnus Gisslén
158 [GO] 2020―Oct―03 Erratum to: Virucidal Efficacy of Different Oral Rinses Against Severe Acute Respiratory Syndrome Coronavirus 2 Toni Luise Meister, Yannick Brüggemann, Daniel Todt, Carina Conzelmann, Janis A Müller, Rüdiger Groß, et al. (+6)
159 [GO] 2020―Oct―01 From Foe to Friend in COVID-19: RAS Inhibitors Jason Kidde, Amirhossein Sahebkar
160 [GO] 2020―Oct―01 Comparing Clinical Characteristics of Influenza and Common Coronavirus Infections using Electronic Health Records Dadong Li, Donna M Wolk, Michael N Cantor
161 [GO] 2020―Oct―01 Minor allele of Interferon-Induced Transmembrane Protein-3 (IFITM3) polymorphism (rs12252) is covered against SARS-CoV-2 infection and mortality: a worldwide epidemiological investigation Abhijit Pati, Sunali Padhi, Subham Suvankar, Aditya K Panda
162 [GO] 2020―Sep―26 Clinical presentation and outcomes of SARS-CoV-2 related encephalitis: the ENCOVID multicentre study Andrea Pilotto, Stefano Masciocchi, Irene Volonghi, Massimo Crabbio, Eugenio Magni, Valeria De Giuli, et al. (+23)
163 [GO] 2020―Sep―16 No SARS-CoV-2 neutralization by intravenous immunoglobulins produced from plasma collected before the 2020 pandemic Julia Schwaiger, Michael Karbiener, Claudia Aberham, Maria R Farcet, Thomas R Kreil
164 [GO] 2020―Sep―15 A granulocytic signature identifies COVID-19 and its severity Joana Vitte, Aïssatou Bailo Diallo, Asma Boumaza, Alexandre Lopez, Moïse Michel, Jérôme Allardet-Servent, et al. (+10)
165 [GO] 2020―Sep―09 Corrigendum to: COVID-19 Epidemic Doubling Time in the United States Before and During Stay-at-Home Restrictions Mark N Lurie, Joe Silva, Rachel R Yorlets, Jun Tao, Philip A Chan
166 [GO] 2020―Sep―09 Corrigendum to: Environmental Sampling for Severe Acute Respiratory Syndrome Coronavirus 2 During a COVID-19 Outbreak on the Diamond Princess Cruise Ship Takuya Yamagishi, Makoto Ohnishi, Nobuaki Matsunaga, Kensaku Kakimoto, Hajime Kamiya, Kiyoko Okamoto, et al. (+23)
167 [GO] 2020―Sep―08 Post-Mortem Findings in Italian Patients with COVID-19 - a Descriptive Full Autopsy Study of cases with and without co-morbidities Laura Falasca, Roberta Nardacci, Daniele Colombo, Eleonora Lalle, Antonino Di Caro, Emanuele Nicastri, et al. (+11)
168 [GO] 2020―Sep―08 SARS-CoV-2 Antibody Avidity Responses in COVID-19 Patients and Convalescent Plasma Donors Sarah E Benner, Eshan U Patel, Oliver Laeyendecker, Andrew Pekosz, Kirsten Littlefield, Yolanda Eby, et al. (+19)
169 [GO] 2020―Sep―02 A study of universal SARS-CoV-2 RNA testing of residents and staff in a large group of care homes in South London Agnes Marossy, Stefan Rakowicz, Angela Bhan, Sarah Noon, Amanda Rees, Manjinder Virk, et al. (+5)
170 [GO] 2020―Sep―01 Immunosenescence and SARS-CoV-2 Vaccine Development David Nalin
171 [GO] 2020―Aug―04 Clinical and epidemiological features of 46 children under 1 year old with coronavirus disease 2019 (COVID-19) in Wuhan, China: a descriptive study Xinghua Liu, Rong Xie, Wei Li, Yan Guo, Bo Zhang, Yue Zhang, et al. (+8)
172 [GO] 2020―Aug―04 Factors associated with viral load kinetics of Middle East respiratory syndrome coronavirus during the 2015 outbreak in South Korea Jeong-Sun Yang, Min-Gyu Yoo, Hye-Ja Lee, Han Byul Jang, Hee-Dong Jung, Jeong-Gu Nam, et al. (+3)
173 [GO] 2020―Aug―04 Common human coronaviruses seem at least as severe as influenza in patients hospitalized with acute respiratory infection: results from 8-year hospital-based surveillance in Q, Canada Rodica Gilca, Sara Carazo, Rachid Amini, Hugues Charest, Gaston De Serres
174 [GO] 2020―Aug―04 SARS-CoV-2-specific antibody detection for sero-epidemiology: a multiplex analysis approach accounting for accurate seroprevalence Gerco den Hartog, Rutger M Schepp, Marjan Kuijer, Corine GeurtsvanKessel, Josine van Beek, Nynke Rots, et al. (+3)
175 [GO] 2020―Aug―04 Evaluation of Serological Tests for SARS-CoV-2: Implications for Serology Testing in a Low-Prevalence Setting Katherine Bond, Suellen Nicholson, Seok Ming Lim, Theo Karapanagiotidis, Eloise Williams, Douglas Johnson, et al. (+9)
176 [GO] 2020―Aug―01 Transient lymphopenia and interstitial pneumonia with endotheliitis in SARS-CoV-2-infected macaques Bon-Sang Koo, Hanseul Oh, Green Kim, Eun-Ha Hwang, Hoyin Jung, Youngjeon Lee, et al. (+4)
177 [GO] 2020―Jul―31 Prospective study comparing deep-throat saliva with other respiratory tract specimens in the diagnosis of novel coronavirus disease (COVID-19) Christopher K C Lai, Zigui Chen, Grace Lui, Lowell Ling, Timothy Li, Martin C S Wong, et al. (+9)
178 [GO] 2020―Jul―31 COVID-19 epidemic doubling time in the United States before and during stay-at-home restrictions Mark N Lurie, Joe Silva, Rachel R Yorlets, Jun Tao, Philip A Chan
179 [GO] 2020―Jul―31 Immunoserologic detection and diagnostic relevance of cross-reactive auto-antibodies in COVID-19 patients María Teresa Schiaffino, Marisa Di Natale, Elena García-Martínez, Joaquín Navarro, José Luis Muñoz-Blanco, Pablo Demelo-Rodríguez, Paloma Sánchez-Mateos
180 [GO] 2020―Jul―17 Environmental sampling for severe acute respiratory syndrome coronavirus 2 during COVID-19 outbreak in the Diamond Princess cruise ship Takuya Yamagishi, Makoto Ohnishi, Nobuaki Matsunaga, Kensaku Kakimoto, Hajime Kamiya, Kiyoko Okamoto, et al. (+23)
181 [GO] 2020―Jul―06 Direct observation of repeated infections with endemic coronaviruses Marta Galanti, Jeffrey Shaman
182 [GO] 2020―Jul―05 Overcoming Challenges in COVID-19 Translational Research Jonathan Z Li, Xu G Yu
183 [GO] 2020―Jun―28 The Definition and Risks of Cytokine Release Syndrome in 11 COVID-19-Affected Critically Ill Patients with Pneumonia: Analysis of Disease Characteristics Wenjun Wang, Xiaoqing Liu, Sipei Wu, Sibei Chen, Yimin Li, Lingbo Nong, et al. (+5)
184 [GO] 2020―Jun―26 Clinical characteristics and factors associated with long-term viral excretion in patients with SARS-CoV-2 infection: a single center 28-day study Ding Shi, Wenrui Wu, Qing Wang, Kaijin Xu, Jiaojiao Xie, Jingjing Wu, et al. (+7)
185 [GO] 2020―Jun―24 Clinical outcomes and immunologic characteristics of Covid-19 in people with HIV Hsi-en Ho, Michael J Peluso, Colton Margus, Joao Pedro Matias Lopes, Chen He, Michael M Gaisa, et al. (+3)
186 [GO] 2020―Jun―23 Racial Disparity of Coronavirus Disease 2019 (COVID-19) in African American Communities Ravina Kullar, Jasmine R Marcelin, Talia H Swartz, Damani A Piggott, Raul Macias Gil, Trini A Mathew, Tina Tan
187 [GO] 2020―Jun―23 Group Testing for Sars-Cov-2 to Enable Rapid Scale-Up of Testing and Real-Time Surveillance of Incidence Christopher D Pilcher, Daniel Westreich, Michael G Hudgens
188 [GO] 2020―Jun―20 Suboptimal biological sampling as a probable cause of false-negative COVID-19 diagnostic test results Natalie N Kinloch, Gordon Ritchie, Chanson J Brumme, Winnie Dong, Weiyan Dong, Tanya Lawson, et al. (+8)
189 [GO] 2020―Jun―19 Serum Cytokine and Chemokine profile in Relation to the Severity of Coronavirus disease 2019 (COVID-19) in China Ying Chi, Yiyue Ge, Bin Wu, Wenshuai Zhang, Tao Wu, Tian Wen, et al. (+7)
190 [GO] 2020―Jun―16 Elevation of liver fibrosis index FIB-4 is associated with poor clinical outcomes in patients with COVID-19 Luis Ibáñez-Samaniego, Federico Bighelli, Clara Usón, Celia Caravaca, Carlos Fernández Carrillo, Miriam Romero, et al. (+9)
191 [GO] 2020―Jun―16 Ethical implementation of ‘immunity passports’ during the COVID-19 pandemic Teck Chuan Voo, Hannah Clapham, Clarence C Tam
192 [GO] 2020―Jun―16 Identifying capability framework that could mitigate the COVID-19 pandemic in global health community Martin C S Wong, Junjie Huang, Jeremy Y C Teoh, Sunny H Wong
193 [GO] 2020―Jun―16 Attenuated interferon and pro-inflammatory response in SARS-CoV-2-infected human dendritic cells is associated with viral antagonism of STAT1 phosphorylation Dong Yang, Hin Chu, Yuxin Hou, Yue Chai, Huiping Shuai, Andrew Chak-Yiu Lee, et al. (+11)
194 [GO] 2020―Jun―15 Interferon-β 1a inhibits SARS-CoV-2 in vitro when administered after virus infection Nicola Clementi, Roberto Ferrarese, Elena Criscuolo, Roberta Antonia Diotti, Matteo Castelli, Carolina Scagnolari, et al. (+4)
195 [GO] 2020―Jun―08 Airborne SARS-CoV-2 is Rapidly Inactivated by Simulated Sunlight Michael Schuit, Shanna Ratnesar-Shumate, Jason Yolitz, Gregory Williams, Wade Weaver, Brian Green, et al. (+13)
196 [GO] 2020―Jun―05 Corrigendum to: A 55-Day-Old Female Infant Infected With 2019 Novel Coronavirus Disease: Presenting With Pneumonia, Liver Injury, and Heart Damage Yuxia Cui, Maolu Tian, Dong Huang, Xike Wang, Yuying Huang, Li Fan, et al. (+13)
197 [GO] 2020―Jun―03 Estimating global epidemiology of low pathogenic human coronaviruses relating to the COVID-19 context Pengfei Li, Jiaye Liu, Zhongren Ma, Wichor M Bramer, Maikel P Pepelenbosch, Qiuwei Pan
198 [GO] 2020―Jun―03 SARS-CoV-2 Human Challenge Trials: Too Risky, Too Soon Liza Dawson, Jake Earl, Jeffrey Livezey
199 [GO] 2020―May―29 TPE-nAbs combination therapy for severe COVID-19 Miroslav Malkovsky
200 [GO] 2020―May―29 Decreased B cells on admission was associated with prolonged viral RNA shedding from respiratory tract in Coronavirus Disease 2019: a case control study Shaorui Hao, Jiangshan Lian, Yingfeng Lu, Hongyu Jia, Jianhua Hu, Guodong Yu, et al. (+17)
201 [GO] 2020―May―29 Multistate Outbreak of Seoul virus: Implications for the One Health Movement and Pandemic Preparedness Mary-Margaret A Fill
202 [GO] 2020―May―27 Performance of SARS-CoV-2 antibody assays in different stages of the infection: Comparison of commercial ELISA and rapid tests M Traugott, S W Aberle, J H Aberle, H Griebler, M Karolyi, E Pawelka, et al. (+3)
203 [GO] 2020―May―21 Transmission of SARS-CoV-2 via close contact and respiratory droplets among hACE2 mice Linlin Bao, Hong Gao, Wei Deng, Qi Lv, Haisheng Yu, Mingya Liu, et al. (+19)
204 [GO] 2020―May―20 Testing for Novel Covid-19 antibodies: a necessary adjunct Marco Daverio, Angela Amigoni, Maria Elena Cavicchiolo
205 [GO] 2020―May―19 Extended ORF8 Gene Region Is Valuable in the Epidemiological Investigation of SARS-similar Coronavirus Shuaiyin Chen, Xin Zheng, Jingyuan Zhu, Ronghua Ding, Yuefei Jin, Weiguo Zhang, et al. (+4)
206 [GO] 2020―May―16 Detection of Nucleocapsid Antibody to SARS-CoV-2 is More Sensitive than Antibody to Spike Protein in COVID-19 Patients Peter D Burbelo, Francis X Riedo, Chihiro Morishima, Stephen Rawlings, Davey Smith, Sanchita Das, et al. (+4)
207 [GO] 2020―May―16 Influence of storage conditions on SARS-CoV-2 nucleic acid detection in throat swabs Lin Li, Xiao Li, Zhengdong Guo, Zhongyi Wang, Ke Zhang, Chao Li, et al. (+2)
208 [GO] 2020―May―06 T cell subset counts in peripheral blood can be used as discriminatory biomarkers for diagnosis and severity prediction of COVID-19 Mei Jiang, Yang Guo, Qing Luo, ZiKun Huang, Rui Zhao, ShuYuan Liu, et al. (+3)
209 [GO] 2020―May―04 A Peptide-based Magnetic Chemiluminescence Enzyme Immunoassay for Serological Diagnosis of Coronavirus Disease 2019 (COVID-19) Xue-fei Cai, Juan Chen, Jie-li Hu, Quan-xin Long, Hai-jun Deng, Kai Fan, et al. (+28)
210 [GO] 2020―May―04 Clinical characteristics of patients with COVID-19 in Japan: a single-center case series Ken-ichiro Kobayashi, Takahiro Kaki, Shinsuke Mizuno, Kenji Kubo, Nobuhiro Komiya, Satoko Otsu
211 [GO] 2020―Apr―30 Balancing Expediency and Scientific Rigor in SARS-CoV-2 Vaccine Development Kevin W Graepel, Sonali Kochhar, Ellen W Clayton, Kathryn E Edwards
212 [GO] 2020―Apr―28 Interferon-induced transmembrane protein-3 genetic variant rs12252-C is associated with disease severity in COVID-19 Yonghong Zhang, Ling Qin, Yan Zhao, Ping Zhang, Bin Xu, Kang Li, et al. (+10)
213 [GO] 2020―Apr―28 Longitudinal Change of SARS-Cov2 Antibodies in Patients with COVID-19 Guoxin Zhang, Shuke Nie, Zhaohui Zhang, Zhentao Zhang
214 [GO] 2020―Apr―28 Effect of Convalescent Plasma Therapy on Viral Shedding and Survival in COVID-19 Patients Qing-Lei Zeng, Zu-Jiang Yu, Jian-Jun Gou, Guang-Ming Li, Shu-Huan Ma, Guo-Fan Zhang, et al. (+8)
215 [GO] 2020―Apr―23 COVID-19: Is Everything Appropriate to Create an Effective Vaccine? Andrea Cioffi
216 [GO] 2020―Apr―22 Epidemiological characteristics and incubation period of 7,015 confirmed cases with Coronavirus Disease 2019 outside Hubei Province in China Xiuquan Nie, Lieyang Fan, Ge Mu, Qiyou Tan, Mengyi Wang, Yujia Xie, et al. (+4)
217 [GO] 2020―Apr―21 Transmission potential of asymptomatic and paucisymptomatic SARS-CoV-2 infections: a three-family cluster study in China Xiao-Lin Jiang, Xiao-Li Zhang, Xiang-Na Zhao, Cun-Bao Li, Jie Lei, Zeng-Qiang Kou, et al. (+13)
218 [GO] 2020―Apr―21 Desperate times call for temperate measures: practicing infectious diseases during a novel pandemic Mark J Siedner, Rajesh T Gandhi, Arthur Y Kim
219 [GO] 2020―Apr―20 Epidemiological and clinical characteristics of 26 asymptomatic SARS-CoV-2 carriers Yanfeng Pan, Xue Yu, Xinwei Du, Qingqing Li, Xianyang Li, Tao Qin, et al. (+7)
220 [GO] 2020―Apr―15 Airborne or droplet precautions for health workers treating COVID-19? Prateek Bahl, Con Doolan, Charitha de Silva, Abrar Ahmad Chughtai, Lydia Bourouiba, C Raina MacIntyre
221 [GO] 2020―Apr―14 Epidemiology of seasonal coronaviruses: Establishing the context for COVID-19 emergence Sema Nickbakhsh, Antonia Ho, Diogo F P Marques, Jim McMenamin, Rory N Gunson, Pablo R Murcia
222 [GO] 2020―Apr―08 My Future in Medicine: How COVID-19 is Inspiring the Next Generation of Infectious Disease Specialists Jawara Allen
223 [GO] 2020―Apr―03 Coronavirus occurrence and transmission over 8 years in the HIVE cohort of households in Michigan Arnold S Monto, Peter DeJonge, Amy P Callear, Latifa A Bazzi, Skylar Capriola, Ryan E Malosh, et al. (+2)
224 [GO] 2020―Mar―31 Human challenge studies to accelerate coronavirus vaccine licensure Nir Eyal, Marc Lipsitch, Peter G Smith
225 [GO] 2020―Mar―28 Characteristics of peripheral lymphocyte subset alteration in COVID-19 pneumonia Fan Wang, Jiayan Nie, Haizhou Wang, Qiu Zhao, Yong Xiong, Liping Deng, et al. (+4)
226 [GO] 2020―Mar―14 Public health measures to slow community spread of COVID-19 Benjamin J Cowling, Allison Aiello
227 [GO] 2020―Feb―15 A Familial Cluster of Infection Associated With the 2019 Novel Coronavirus Indicating Possible Person-to-Person Transmission During the Incubation Period Ping Yu, Jiang Zhu, Zhengdong Zhang, Yingjun Han
 [1] 

227 Results       Page 1



[de][en]

Last change 2022―Feb―03 17:06:14 UTC

© Daten-Quadrat 2022       Done in 0.009 sec